(Reuters) – Novavax Inc said on Monday it had received interim authorization from the Singapore Health Sciences Authority (HSA) for its COVID-19 vaccine in adults.
(Reporting by Dania Nadeem in Bengaluru)
Novavax COVID vaccine gets interim authorization in Singapore
Feb 14, 2022 | 4:17 PM
